Skip to main content

Table 2 A subgroup analysis of the prevalence of depressive symptoms among HIV AIDS patients in Ethiopia with its 95% confidence interval

From: Depressive symptoms and their determinants in patients who are on antiretroviral therapy in the case of a low-income country, Ethiopia: a systematic review and meta-analysis

Subgroup Number of studies Estimates Heterogeneity
Prevalence (%) 95% CI I2 Q(DF) P-value
Study setting
 North western Ethiopia (Amhara region) 5 31.16 17.43, 44.89 96.2% 185.27 (4) P < 0.001
 South western Ethiopia(Oromia region) 3 59.43 42.44, 76.42 99.5% 403.2 (2) P < 0.001
 Tigray region 3 38.8 14.66, 62.94 94.8% 212 (2) P < 0.001
 Central Ethiopia(Addis Ababa) 6 30.61 18.82, 42.41 92. 2% 95.43 (5) P < 0.001
 Southern Ethiopia 4 29.25 11.45, 47.05 96% 164.20 (3) P < 0.001
Assessment tool used
 PHQ-9 12 37.62 30.05, 45.17 98.8% 521.45 (11) P < 0.001
 HADS 2 26.2 3.20, 55.60 94.6% 453.21 (1) P < 0.001
 CES-D 3 32.37 − 14.05, 78.79 96.4% 496.32 (2) P < 0.001
 BDI 2 45.6 25.76, 66.54 92.6% 243.40 (1) P < 0.001
 Others* 2 29.4 1.13, 55.77 98.6% 502.65 (1) P < 0.001
Sample size studied
 ≤ 400 8 47.7 36.73, 58.57 99% 232.21 (7) P < 0.001
 > 400  13 28.5 20.21, 36.72 96.8% 136.35 (12) P < 0.001
Year of publication
 After 2015 11 40 31.17, 48.89 96.6% 221.22 (10) P < 0.001
  2015 and before 10 31.1 19.62, 42.56 98% 311.37 (9) P < 0.001
  1. Others* Includes HAM-D & Kessler-6, DF Degree of Freedom, CI confidence interval